Group 1 - Stone Fox Capital is a Registered Investment Advisor (RIA) based in Oklahoma, led by Mark Holder, a CPA with 30 years of investing experience, including 15 years as a portfolio manager [1] - Mark Holder leads the investing group Out Fox The Street, which provides stock picks and in-depth research aimed at identifying potential multibaggers while managing portfolio risk through diversification [1] - The features of Out Fox The Street include various model portfolios, stock picks with identifiable catalysts, daily updates, real-time alerts, and access to community chat and direct communication with Mark for inquiries [1]

Core Viewpoint - The approximately 45% correction in Hims & Hers Health (HIMS) presents a potential investment opportunity for those who missed the rally in 2024-25 [1] Group 1: Company Overview - Hims & Hers Health has experienced a significant market downturn, which may create favorable conditions for investors [1] Group 2: Analyst Background - The analysis is conducted by a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management, focusing on equity valuation and market trends [1] - The analyst has a background as a former Vice President at Barclays, leading teams in model validation and stress testing, indicating a strong expertise in both fundamental and technical analysis [1] Group 3: Research Approach - The research approach combines rigorous risk management with a long-term perspective on value creation, emphasizing macroeconomic trends, corporate earnings, and financial statement analysis [1]

Core Viewpoint - The approximately 45% correction in Hims & Hers Health (HIMS) presents a potential investment opportunity for those who missed the rally in 2024-25 [1] Group 1: Market Analysis - The markets have experienced a significant downturn, which may create favorable conditions for investors [1] Group 2: Analyst Background - The analysis is conducted by a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management [1] - The analyst has a strong focus on equity valuation, market trends, and portfolio optimization to identify high-growth investment opportunities [1] - Previous experience includes a role as Vice President at Barclays, leading teams in model validation, stress testing, and regulatory finance [1] Group 3: Research Approach - The research approach combines rigorous risk management with a long-term perspective on value creation [1] - There is a particular interest in macroeconomic trends, corporate earnings, and financial statement analysis to provide actionable investment ideas [1]

Core Viewpoint - The article emphasizes the importance of conducting thorough personal research and due diligence before making investment decisions, highlighting the inherent risks involved in trading [3]. Group 1 - The analysis is intended solely for informational purposes and should not be interpreted as professional investment advice [3]. - There is a clear disclaimer regarding the lack of any stock or derivative positions in the companies mentioned, indicating a neutral stance [2]. - The article expresses the author's personal opinions and does not reflect the views of any affiliated organization [4].

Group 1 - The focus is on growth and dividend income as a strategy for retirement planning [1] - The portfolio is structured to generate monthly dividend income that grows through reinvestment and annual increases [1] Group 2 - The article emphasizes the importance of conducting personal research before making investment decisions [2] - It clarifies that the opinions expressed are personal and not intended as specific investment advice [2][3]

Core Viewpoint - Hims & Hers Health Inc. (HIMS) shares have decreased by 30% since the last rating, while the overall market has increased by 5% [1] Company Performance - The significant decline in HIMS shares indicates underperformance compared to the market [1] Analyst Perspective - The analyst has a long position in HIMS shares, indicating a personal investment interest in the company [2]

Group 1 - Hims & Hers Health Inc. (HIMS) shares have decreased by 30% since the last rating, while the market has increased by 5%, indicating underperformance [1] - The company is focused on providing health and wellness products, but recent stock performance raises concerns about its market position [1] Group 2 - The analyst has a beneficial long position in HIMS shares, indicating confidence in the company's potential despite recent stock declines [2] - The analysis reflects a broader investment strategy that includes technology and crypto opportunities, suggesting a diverse approach to market trends [2]

Core Insights - Hims & Hers Health, Inc. (HIMS) emphasizes the role of data and AI in creating a personalized healthcare experience, enhancing customer interactions and outcomes [1][6] - The company has launched Labs for tracking biomarkers and is investing in AI to improve clinical decision-making and care personalization [2][6] Company Developments - Hims & Hers introduced Labs, allowing customers to monitor key biomarkers and connect results to actionable plans developed by doctors [2] - The company is enhancing its MedMatch capabilities and AI workflows to improve diagnosis and care quality [6] Market Performance - Hims & Hers shares have increased by 24.2% over the past year, contrasting with a 5.2% decline in the industry [5] - The forward 12-month price-to-sales ratio for HIMS is 2.8X, lower than the industry average of 4.6X but higher than its three-year median of 2.6X [9] Earnings Estimates - The Zacks Consensus Estimate predicts a 77.8% increase in HIMS' earnings per share from 2024 to 2025 [7] - Current estimates for HIMS' earnings per share for the next year are 0.59, reflecting a year-over-year growth of 22.33% [10]

Market Sentiment - The stock market mood at the beginning of 2026 is characterized by nervousness among investors [1] - There is skepticism regarding the ability of large-cap growth stocks to maintain high valuation premiums amid soft macroeconomic conditions [1] Analyst Background - Gary Alexander has extensive experience in covering technology companies on Wall Street and working in Silicon Valley [1] - He has served as an adviser to several seed-round startups and has been a contributor on Seeking Alpha since 2017 [1] - His insights are widely disseminated, being quoted in various web publications and featured on trading apps like Robinhood [1]

Core Viewpoint - Hims and Hers Health (HIMS) shares are experiencing a decline, with current trading at approximately $32.23, down by $0.82, indicating mixed sentiment in options trading [1] Options Trading Summary - Options volume is consistent with average levels, with 81,000 contracts traded, and calls outpacing puts, resulting in a put/call ratio of 0.73, compared to a typical level of 0.59 [1] - Implied volatility (IV30) has increased by 3.1 points, reaching 60.94, which is in the lowest 10% of observations over the past year, suggesting an expected daily price movement of $1.24 [1] - The put-call skew has flattened, indicating a modestly bullish sentiment among traders [1]